Fig. 2.
Fig. 2. Unique nonsense mutations are identified in patients HLH-SM and HLH-MP. / (A) Automated sequence analysis of exon 2 reveals a C462T nucleotide substitution (shown with an arrow) in patient HLH-SM (lower left-hand panel), that is predicted to substitute a stop codon for Arg55. Similarly, sequence analysis of exon 3 reveals a T527A nucleotide change in patient HLH-MP (lower right-hand panel), changing Tyr76 to a stop codon. (B) Schematic representation of the full-length SH2D1A complementary DNA and protein, and the location of both point mutations that are predicted to result in premature truncation within the SH2D1A SH2 domain.

Unique nonsense mutations are identified in patients HLH-SM and HLH-MP.

(A) Automated sequence analysis of exon 2 reveals a C462T nucleotide substitution (shown with an arrow) in patient HLH-SM (lower left-hand panel), that is predicted to substitute a stop codon for Arg55. Similarly, sequence analysis of exon 3 reveals a T527A nucleotide change in patient HLH-MP (lower right-hand panel), changing Tyr76 to a stop codon. (B) Schematic representation of the full-length SH2D1A complementary DNA and protein, and the location of both point mutations that are predicted to result in premature truncation within the SH2D1A SH2 domain.

Close Modal

or Create an Account

Close Modal
Close Modal